These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6236702)
1. Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate. Werbel LM; Jacobs RL; Steinkampf RW; Worth DF Am J Trop Med Hyg; 1984 Jul; 33(4):526-33. PubMed ID: 6236702 [TBL] [Abstract][Full Text] [Related]
2. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys. Schmidt LH; Rossan RN Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864 [TBL] [Abstract][Full Text] [Related]
3. The activity of drug combinations against established infections of rodent malaria. Hill J Parasitology; 1987 Aug; 95 ( Pt 1)():17-23. PubMed ID: 3313204 [TBL] [Abstract][Full Text] [Related]
4. Protection against Plasmodium berghei yoelii in chloroquine- and pyrimethamine-treated mice. Pradhan VR; Renapurkar DM Folia Parasitol (Praha); 1984; 31(4):371-3. PubMed ID: 6510839 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic activity of combination doses of chloroquine, pyrimethamine, and sulfamethoxy-diazine, a long-acting sulfanilamide, against Plasmodium berghei infections in mice. Berberian DA; Slighter RG Antimicrob Agents Chemother; 1973 Mar; 3(3):392-8. PubMed ID: 4597722 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the pyrimethamine and cycloguanil sensitivities of the pre-erythrocytic and erythrocytic stages of drug-sensitive and -resistant strains of Plasmodium yoelii. Howells RE; Gilles HM; Bent NS Ann Trop Med Parasitol; 1985 Jun; 79(3):247-51. PubMed ID: 4026437 [TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of malaria in man using the sulfone DFD with pyrimethamine. Clyde DF; Rebert CC; McCarthy VC; Miller RM Mil Med; 1973 Jul; 138(7):418-21. PubMed ID: 4198482 [No Abstract] [Full Text] [Related]
8. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate. Stewart LB; Peters W; Robinson BL Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710 [TBL] [Abstract][Full Text] [Related]
9. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815 [TBL] [Abstract][Full Text] [Related]
10. Fansidar prophylaxis, therapy, and immune responses in rodent malaria (Plasmodium berghei). Ferraroni JJ; Speer CA J Parasitol; 1982 Aug; 68(4):609-15. PubMed ID: 6750070 [TBL] [Abstract][Full Text] [Related]
11. Sustained-release implants in the chemotherapy of experimental rodent malaria II. The effects of sulphadiazine, pyrimethamine and cycloguanil in biodegradable polymer matrices. Judge BM; Howells RE; Graham NB; McNeill ME Ann Trop Med Parasitol; 1981 Oct; 75(5):511-9. PubMed ID: 7032431 [No Abstract] [Full Text] [Related]
12. Plasmodium berghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model. Muregi FW; Kano S; Kino H; Ishih A Exp Parasitol; 2009 Apr; 121(4):376-80. PubMed ID: 19271282 [TBL] [Abstract][Full Text] [Related]
13. Treatment of falciparum malaria with a single dose combination of dapsone and pyrimethamine (Maloprim). Ponnampalam JT; Richards PN Singapore Med J; 1983 Oct; 24(5):303-6. PubMed ID: 6367060 [No Abstract] [Full Text] [Related]
14. Experimental studies of the potentiation of proguanil and pyrimethamine by dapsone using Plasmodium berghei in white mice. Black RH; Ray AP Ann Trop Med Parasitol; 1977 Jun; 71(2):131-9. PubMed ID: 326205 [TBL] [Abstract][Full Text] [Related]
15. Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine. Cook IF; Kish MY Med J Aust; 1985 Aug; 143(4):139-41. PubMed ID: 4021907 [TBL] [Abstract][Full Text] [Related]
16. Malaria prophylaxis. du Preez O; Cockcroft CR S Afr Med J; 1975 Aug; 49(34):1407-8. PubMed ID: 1099692 [TBL] [Abstract][Full Text] [Related]
17. ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme. Greenwood BM; Greenwood AM; Bradley AK; Shenton FC; Smith AW; Snow RW; Williams K; Eggelte TA; Huikeshoven H; de Wit M Bull World Health Organ; 1986; 64(6):909-16. PubMed ID: 3493860 [TBL] [Abstract][Full Text] [Related]
18. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409 [TBL] [Abstract][Full Text] [Related]
19. Malaria prophylaxis for travellers. Cook IF Med J Aust; 1985 Apr; 142(7):427. PubMed ID: 3884983 [No Abstract] [Full Text] [Related]
20. Efficacy of dapsone with pyrimethamine (Maloprim) for malaria prophylaxis in Maputo, Mozambique. Pividal J; Viktinski V; Streat E; Schapira A East Afr Med J; 1992 Jun; 69(6):303-5. PubMed ID: 1505413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]